Nanalysis Announces Second Quarter 2025 Conference Call
Rhea-AI Summary
Nanalysis Scientific Corp. (OTCQX: NSCIF), a leader in portable NMR instruments and imaging technology, has scheduled its Q2 2025 earnings conference call for August 28th, 2025 at 5:00 PM ET. CEO Sean Krakiwsky and CFO Randall McRae will host the call to discuss results for the quarter ended June 30, 2025.
Investors can participate by dialing 1-437-900-0527 or 1-888-510-2154 from abroad, or access the webcast through the company's investor relations website. A separate European Q&A session will be held on August 29th at 8:30 AM ET. The webcast will be archived for 90 days, and a playback will be available for seven days.
Positive
- None.
Negative
- None.
Hosting Call at 5:00 pm ET on Thursday, August 28th
European Q&A Session on Friday, August 29th at 8:30am ET
Investors interested in participating in the live call can dial 1-437-900-0527 or 1-888-510-2154 from abroad. Investors can also access the call online through a listen-only webcast here: https://app.webinar.net/qrKemn9Rxv0 or on the investor relations section of the Company's website HERE.
The webcast will be archived on the Company's investor relations webpage for at least 90 days, and a telephonic playback will be available for seven days after the conference call by calling 1-888-660-6345 or 1-289-819-1450, conference ID # 83432.
Additionally, the Company will be hosting a Q&A session for its European investors at 8:30am ET on Friday, August 29th which can be accessed by the following link: Join the meeting now.
About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA:1N1)
Nanalysis Scientific Corp. in operates two primary business segments: Scientific Equipment and Security Services. Within its Scientific Equipment business is what the Company terms "MRI and NMR for industry". The Company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The Company has followed up that initial offering with new products and continues to have a strong innovation pipeline. In 2020, the Company announced the launch of its 100MHz platform, which has the highest usable field on a fully featured benchtop NMR on the market. In early 2025, the Company launched its new 60MHz instrument which is based on the successful 100MHz product line. The Company's devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company is working to expand into new global market opportunities independently and with partners. With its partners, the Company provides scientific equipment sales and maintenance services globally.
Within the Company's Security Services business, the core activity is providing airport security equipment maintenance in each province and territory of Canada. In addition, the Company provides commercial security equipment installation and maintenance services to a variety of customers in North America.
Notice regarding Forward Looking Statements and Legal Disclaimer
This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nanalysis-announces-second-quarter-2025-conference-call-302536251.html
SOURCE Nanalysis Scientific Corp.
FAQ
When is Nanalysis Scientific (NSCIF) Q2 2025 earnings call?
How can investors access the Nanalysis Scientific (NSCIF) Q2 2025 earnings call?
When is the Nanalysis Scientific European Q&A session?
How long will the Nanalysis Scientific Q2 2025 earnings call replay be available?
